Related references
Note: Only part of the references are listed.A Combination Vaccine Consisting of Three Live Attenuated Enterotoxigenic Escherichia coli Strains Expressing a Range of Colonization Factors and Heat-Labile Toxin Subunit B Is Well Tolerated and Immunogenic in a Placebo-Controlled Double-Blind Phase I Trial in Healthy Adults
Clayton Harro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli Vaccines
Clayton Harro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)
Chad K. Porter et al.
VACCINE (2011)
Prolonged Episodes of Acute Diarrhea Reduce Growth and Increase Risk of Persistent Diarrhea in Children
Sean R. Moore et al.
GASTROENTEROLOGY (2010)
Global, regional, and national causes of child mortality in 2008: a systematic analysis
Robert E. Black et al.
LANCET (2010)
Estimating child mortality due to diarrhoea in developing countries
Cynthia Boschi-Pinto et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Enteric infections, diarrhea, and their impact on function and development
William A. Petri et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Economic aspects of travelers' diarrhea
Mathyas Wang et al.
JOURNAL OF TRAVEL MEDICINE (2008)
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea:: a phase II, randomised, double-blind, placebo-controlled field trial
Sarah A. Frech et al.
LANCET (2008)
A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E-coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC
Robin McKenzie et al.
VACCINE (2008)
Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC):: Protective efficacy in a double-blind, placebo-controlled challenge study
Robin McKenzie et al.
VACCINE (2007)
Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli
T. S. Coster et al.
INFECTION AND IMMUNITY (2007)
Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers
C. M. Carpenter et al.
VACCINE (2006)
Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age:: Dosing studies in different age groups
F Qadri et al.
VACCINE (2006)
Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults
R McKenzie et al.
INFECTION AND IMMUNITY (2006)
Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic Escherichia coli cholera toxin B subunit vaccine in Israeli young adults
D Cohen et al.
INFECTION AND IMMUNITY (2000)
Share Paper
